EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Day

June 19, 2020

GCF-AGA Grant Awards Newest Research Scholar: Samuel J Klempner, MD

Samuel J. Klempner, M.D., was completing his fellowship at Beth Israel Deaconess Medical Center in Boston when he first became interested in...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

For Deliveries:
Gastric Cancer Foundation
501 Broadway, #338
Millbrae, CA 94030-1907

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

1 week ago

The American Society of Clinical Oncology Gastrointestinal Cancers Symposium will feature several presentations that could change the practice of treating gastric cancer, including data from trials of new targeted therapies, predicts Dr. Mary Feng, radiation oncology professor at UCSF. Via Oncology News Central. #asco2026 #GI26 ... See MoreSee Less

What to Watch for at the 2026 ASCO Gastrointestinal Cancers Symposium

www.oncologynewscentral.com

The first major cancer conference of 2026 will be the American Society of Clinical Oncology’s Gastrointestinal Cancers Symposium, set for Jan. 8–10. Oncology News Central spoke with program commit...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

As part of our mission to accelerate stomach cancer research and improve patient quality of life, Gastric Cancer Foundation is glad to be returning to the annual American Society of Clinical Oncology Gastrointestinal Cancer Symposium from January 8-10, 2026. More than 800 abstracts will be presented! Follow along this week to hear about new research advances for stomach cancer. #GI26 #asco2026 ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

The American Society of Clinical Oncology GI Cancers Symposium is featuring a poster presentation by Stanford University professor Hanlee Ji, primary investigator of the Gastric Cancer Registry - one of our foundation’s signature initiatives. #GI26 #ASCO2026 ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Jazz Pharmaceuticals will present new details from its phase 3 trial of Ziihera (zanidatamab) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The trial, conducted with BeOne Medicines, has already produced clinically meaningful improvements in HER2-positive gastric cancer patients when given with chemotherapy, as well as with chemo and BeOne’s Tevimbra (tislelizumab). #GI26 #ASCO2026 ... See MoreSee Less

ASCO Gastrointestinal Cancers Symposium - ASCO

conferences.asco.org

From studies in progress to late-stage clinical trials, explore more than 800 abstracts and cutting-edge research that will be featured at the 2026 ASCO Gastrointestinal Cancers Symposium.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Astellas Pharma US has big plans for the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, including a late-breaking presentation of cohort results from a phase 2 trial of its targeted gastric cancer drug VYLOY (zolbetuximab) on January 8. #GI26 #asco2026 ... See MoreSee Less

Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium

www.prnewswire.com

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present data on potential treatments for...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

Please join with us to fuel the next wave of progress.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Please join with us to fuel the next wave of progress. Support our 2025 Fundraising Campaign.

Your support honors the memories of those we have lost and creates much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Powering progress to defeat stomach cancer.

Powering progress to defeat stomach cancer.

MORE INFO DONATE DONATE MORE INFO

X